Medicine Description glustacomb 15\850 mg
glustacomb 15/850 mg Tablets is a medication that combines metformin and pioglitazone, both of which play distinct roles in managing blood glucose levels in individuals with type 2 diabetes. Metformin primarily acts by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, thereby facilitating improved glucose uptake in muscle tissues. On the other hand, pioglitazone belongs to the thiazolidinedione class and works by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), which leads to increased insulin sensitivity, particularly in adipose tissue. This dual mechanism not only helps in lowering blood sugar levels but also promotes lipid metabolism and has beneficial effects on cardiovascular health.
Indications and Uses of glustacomb 15/850 mg Tablets
- Management of type 2 diabetes mellitus in adults
- Improvement of insulin sensitivity
- Reduction of blood glucose levels in conjunction with diet and exercise
- May be used as an adjunct to other antidiabetic therapies
Side Effects of glustacomb 15/850 mg Tablets
- Hypoglycemia
- Weight gain
- Edema
- Gastrointestinal disturbances, such as nausea and diarrhea
- Increased risk of heart failure
- Potential liver enzyme elevation
Storage and Handling
Store glustacomb 15/850 mg Tablets at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Patient Advice and Precautions
Patients should adhere to prescribed dietary and exercise recommendations while using glustacomb. Regular monitoring of blood glucose levels is essential for optimal management. Inform your healthcare provider of any history of heart problems or liver disease prior to starting treatment. Do not discontinue use without consulting your doctor, and report any unusual symptoms immediately.